Nuveen Asset Management LLC Grows Stock Holdings in MeiraGTx Holdings plc (NASDAQ:MGTX)

Nuveen Asset Management LLC lifted its holdings in shares of MeiraGTx Holdings plc (NASDAQ:MGTX - Free Report) by 43.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 191,311 shares of the company's stock after purchasing an additional 57,737 shares during the period. Nuveen Asset Management LLC owned about 0.24% of MeiraGTx worth $1,165,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Geode Capital Management LLC increased its holdings in MeiraGTx by 16.4% during the fourth quarter. Geode Capital Management LLC now owns 570,646 shares of the company's stock worth $3,475,000 after buying an additional 80,407 shares during the last quarter. Northern Trust Corp grew its position in shares of MeiraGTx by 18.9% during the 4th quarter. Northern Trust Corp now owns 315,665 shares of the company's stock valued at $1,922,000 after acquiring an additional 50,267 shares during the period. Privium Fund Management B.V. increased its stake in shares of MeiraGTx by 5.2% during the 4th quarter. Privium Fund Management B.V. now owns 225,078 shares of the company's stock worth $1,371,000 after purchasing an additional 11,118 shares during the last quarter. Long Focus Capital Management LLC bought a new stake in shares of MeiraGTx in the 4th quarter worth approximately $1,156,000. Finally, D. E. Shaw & Co. Inc. raised its holdings in shares of MeiraGTx by 41.1% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 123,643 shares of the company's stock worth $753,000 after purchasing an additional 36,008 shares during the period. 67.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

MGTX has been the subject of several research reports. Royal Bank of Canada increased their price objective on MeiraGTx from $11.00 to $13.00 and gave the company an "outperform" rating in a report on Monday, March 17th. Chardan Capital dropped their price target on MeiraGTx from $38.00 to $35.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Finally, Wall Street Zen lowered MeiraGTx from a "hold" rating to a "sell" rating in a report on Thursday, May 22nd.

MeiraGTx Stock Performance

MGTX traded up $0.52 on Friday, hitting $6.00. The company's stock had a trading volume of 436,494 shares, compared to its average volume of 370,306. MeiraGTx Holdings plc has a 12 month low of $3.85 and a 12 month high of $8.75. The firm has a market cap of $482.19 million, a P/E ratio of -4.96, a price-to-earnings-growth ratio of 0.37 and a beta of 1.30. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.86. The company's 50 day simple moving average is $5.67 and its 200-day simple moving average is $6.23.

MeiraGTx (NASDAQ:MGTX - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.38) by ($0.13). MeiraGTx had a negative return on equity of 146.38% and a negative net margin of 633.05%. The company had revenue of $1.93 million for the quarter, compared to analysts' expectations of $4.44 million. Analysts forecast that MeiraGTx Holdings plc will post -1.48 EPS for the current year.

Insider Buying and Selling

In other news, CFO Richard Giroux sold 24,000 shares of the company's stock in a transaction dated Tuesday, April 22nd. The stock was sold at an average price of $6.00, for a total transaction of $144,000.00. Following the sale, the chief financial officer now directly owns 882,494 shares in the company, valued at $5,294,964. This represents a 2.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Alexandria Forbes sold 47,500 shares of the firm's stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of $5.34, for a total transaction of $253,650.00. Following the completion of the transaction, the chief executive officer now owns 1,408,983 shares of the company's stock, valued at $7,523,969.22. This trade represents a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. 7.50% of the stock is currently owned by insiders.

MeiraGTx Company Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.